+ A
A -
A coronavirus vaccine developed by the University of Oxford appears safe and triggers an immune response.
Scientists at Oxford University say their vaccine has been shown in an early trial to prompt a protective immune response in hundreds of people who got the shot.
Trials involving 1,077 people showed the injection led to them making antibodies and T-cells that can fight coronavirus.
The findings are hugely promising, but it is still too soon to know if this is enough to offer protection and larger trials are under way.
In research published on Monday in the journal Lancet, scientists said that they found their experimental COVID-19 vaccine produced a dual immune response in people aged 18 to 55.
“We are seeing good immune response in almost everybody,” said Dr Adrian Hill, director of the Jenner Institute at Oxford University. “What this vaccine does particularly well is trigger both arms of the immune system,” he said.
The vaccine -- called ChAdOx1 nCoV-19 -- is being developed at an unprecedented speed. (Agencies)
Scientists at Oxford University say their vaccine has been shown in an early trial to prompt a protective immune response in hundreds of people who got the shot.
Trials involving 1,077 people showed the injection led to them making antibodies and T-cells that can fight coronavirus.
The findings are hugely promising, but it is still too soon to know if this is enough to offer protection and larger trials are under way.
In research published on Monday in the journal Lancet, scientists said that they found their experimental COVID-19 vaccine produced a dual immune response in people aged 18 to 55.
“We are seeing good immune response in almost everybody,” said Dr Adrian Hill, director of the Jenner Institute at Oxford University. “What this vaccine does particularly well is trigger both arms of the immune system,” he said.
The vaccine -- called ChAdOx1 nCoV-19 -- is being developed at an unprecedented speed. (Agencies)
